{"id":99765,"date":"2025-01-17T00:00:00","date_gmt":"2025-01-17T00:00:00","guid":{"rendered":"https:\/\/enterpriseam.com\/uae\/mubadalas-kelix-bio-acquires-diabtec\/"},"modified":"2025-01-17T00:00:00","modified_gmt":"2025-01-17T00:00:00","slug":"mubadalas-kelix-bio-acquires-diabtec","status":"publish","type":"post","link":"https:\/\/enterpriseam.com\/uae\/2025\/01\/17\/mubadalas-kelix-bio-acquires-diabtec\/","title":{"rendered":"Mubadala\u2019s KELIX bio acquires DiabTec"},"content":{"rendered":"<p style=\"padding:0;margin:0;line-height:1.15;orphans:2;widows:2;text-align:left\"> <strong>KELIX bio closes DiabTec acquisition:<\/strong> <a target=\"_blank\" href=\"https:\/\/www.kelixbio.com\/\" style=\"\" rel=\"noopener\">KELIX bio<\/a>, the biotech arm of Abu Dhabi sovereign wealth fund Mubadala, finalized the acquisition of DiabTec LLC, a subsidiary of Emirati pharma firm <a target=\"_blank\" href=\"https:\/\/www.julphar.net\/en\" style=\"\" rel=\"noopener\">Julphar<\/a>, which focuses on human insulin API manufacturing, according to a <a target=\"_blank\" href=\"https:\/\/www.mubadala.com\/en\/news\/mubadala-s-kelix-bio-acquires-diabtec-llc-bolstering-its-position-in-menas-life-sciences-sector\" style=\"\" rel=\"noopener\">statement<\/a>. The value of the acquisition was not disclosed in the statement.<\/p>\n<p style=\"padding:0;margin:0;line-height:1.15;orphans:2;widows:2;text-align:left\"><strong>The acquisition includes DiabTec\u2019s facility<\/strong>, which features 20k-liter drug substance reactors and a dedicated fill-finish unit for drug products, built to EU and US Food and Drug Administration standards. It is the only facility of its kind in the GCC.<\/p>\n<p style=\"padding:0;margin:0;line-height:1.15;orphans:2;widows:2;text-align:left\"><strong>We knew this was coming: <\/strong>Julphar <a target=\"_blank\" href=\"https:\/\/enterprise.news\/uae\/en\/news\/story\/b430b3f8-5644-4fb9-9c14-e8b408e9e083\/modon-acquires-luxury-real-estate-firm-in-spain-%2B-julphar-sells-insulin-api-manufacturing-subsidiary\" style=\"\" rel=\"noopener\">finalized the sale<\/a> of DiabTec in December, announcing at the time that the transaction \u2014 representing 12.6% of its total assets \u2014 would positively impact its net income by late 2024 or 1Q 2025. The company also confirmed plans to secure insulin API through a supply agreement with DiabTec as part of the deal.<\/p>\n<p style=\"padding:0;margin:0;line-height:1.15;orphans:2;widows:2;text-align:left\"><strong>ICYMI: <\/strong>Mubadala has been actively expanding its healthcare and pharma portfolio, <a target=\"_blank\" href=\"https:\/\/enterprise.news\/uae\/en\/news\/story\/af986379-2d06-4ad2-9258-c0e54ed1f74a\/%253cmark%253e%253c%2Fmark%253emubadala%253cmark%253e%253c%2Fmark%253e-%253cmark%253e%253c%2Fmark%253ebags%253cmark%253e%253c%2Fmark%253e-%253cmark%253e%253c%2Fmark%253emore%253cmark%253e%253c%2Fmark%253e-%253cmark%253e%253c%2Fmark%253ehealthcare%253cmark%253e%253c%2Fmark%253e-%253cmark%253e%253c%2Fmark%253efirms%253cmark%253e%253c%2Fmark%253e-%2B%253cmark%253e%253c%2Fmark%253e%253cmark%253e%253c%2Fmark%253emubadala%253cmark%253e%253c%2Fmark%253e-%253cmark%253e%253c%2Fmark%253ebacked%253cmark%253e%253c%2Fmark%253e-%253cmark%253e%253c%2Fmark%253efirm%253cmark%253e%253c%2Fmark%253e-%253cmark%253e%253c%2Fmark%253esnaps%253cmark%253e%253c%2Fmark%253e-%253cmark%253e%253c%2Fmark%253eup%253cmark%253e%253c%2Fmark%253e-%253cmark%253e%253c%2Fmark%253egerman%253cmark%253e%253c%2Fmark%253e-%253cmark%253e%253c%2Fmark%253ereal%253cmark%253e%253c%2Fmark%253e-%253cmark%253e%253c%2Fmark%253eestate%253cmark%253e%253c%2Fmark%253e-%253cmark%253e%253c%2Fmark%253eassets%253cmark%253e%253c%2Fmark%253e\" style=\"\" rel=\"noopener\">acquiring an 80% stake<\/a> in healthcare logistics firm Global Medical Supply Chain and Al Ittihad Drug Store from Yas Holdings in December. Earlier, in October, KELIX bio <a target=\"_blank\" href=\"https:\/\/enterprise.news\/uae\/en\/news\/story\/0643f3ca-05a7-41a2-821e-969ccdf3761f\/mubadala-owned%253cmark%253e-kelix-%253c%2Fmark%253ebio-acquires-four-globalone-healthcare-pharma-assets\" style=\"\" rel=\"noopener\">acquired<\/a> four biopharma and IV solutions assets, including Bioventure and Gulf Inject, from Yas Holdings\u2019 GlobalOne Healthcare Holding.<\/p>\n<p style=\"padding:0;margin:0;line-height:1.15;orphans:2;widows:2;text-align:left\">\n<p class=\"tag-border-left\">IN OTHER M&A NEWS-<\/p>\n<p style=\"padding:0;margin:0;line-height:1.15;orphans:2;widows:2;text-align:left\"><strong>Investcorp to acquire <\/strong><strong>alternative<\/strong><strong> payments enabler Epipoli: <\/strong>Asset manager Investcorp signed a definitive agreement to acquire Milan-based alternative payments enabler <a target=\"_blank\" href=\"https:\/\/en.epipoli.com\/\" style=\"\" rel=\"noopener\">Epipoli<\/a> from <a target=\"_blank\" href=\"https:\/\/www.bregalmilestone.com\/\" style=\"\" rel=\"noopener\">Bregal Milestone<\/a> and founder and CEO Gaetano Giannetto, according to a company <a target=\"_blank\" href=\"https:\/\/www.investcorp.com\/investcorp-acquires-leading-italian-alternative-payments-enabler-epipoli\/\" style=\"\" rel=\"noopener\">statement<\/a>. The move aims to expand the payments and services platform and ramp up its international presence. The value of the transaction was undisclosed and is subject to customary regulatory and closing conditions. Giannetto will retain a minority stake and continue to lead the company.<\/p>\n<p style=\"padding:0;margin:0;line-height:1.15;orphans:2;widows:2;text-align:left\"><strong>ADVISORS-<\/strong> Clearwater and ADVANT Nctm advised Investcorp, while UBS acted as exclusive financial advisor to Epipoli and Bregal Milestone. PedersoliGattai and Alma LED served as counsels for Epipoli and Bregal Milestone.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>The acquisition includes DiabTec\u2019s state-of-the-art facility, built to EU and US FDA standards<\/p>\n","protected":false},"author":1,"featured_media":99766,"comment_status":"","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"newspack_ads_suppress_ads":false,"newspack_popups_has_disabled_popups":false,"newspack_sponsor_sponsorship_scope":"","newspack_sponsor_native_byline_display":"inherit","newspack_sponsor_native_category_display":"inherit","newspack_sponsor_underwriter_style":"inherit","newspack_sponsor_underwriter_placement":"inherit","ep_exclude_from_search":false,"_primary_brand":0,"newspack_featured_image_position":"","newspack_post_subtitle":"","newspack_article_summary_title":"Overview:","newspack_article_summary":"","newspack_hide_updated_date":false,"newspack_show_updated_date":false,"_jetpack_memberships_contains_paid_content":false,"footnotes":""},"categories":[2392],"tags":[7,131,1235,60,1343,262],"brand":[],"newspack_spnsrs_tax":[],"class_list":["post-99765","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-ma-watch-2","tag-enterpriseam-uae","tag-healthcare","tag-julphar","tag-ma-watch","tag-mubadala","tag-pharmaceuticals","wpautop","entry"],"acf":{"mongo_id":"4c09be09-5b62-456e-9d75-07e75b8170a1","order":"3","is_powered_by":false,"story_type":"1","photo_url":"https:\/\/ent.news\/2024\/2\/1557.jpg","photo_position":"above","homepage_title":"","full_issue_title":"Mubadala\u2019s KELIX bio acquires DiabTec","related_issue":[99760],"teaser":"The acquisition includes DiabTec\u2019s state-of-the-art facility, built to EU and US FDA standards","voice_url":"https:\/\/s3.us-east-1.amazonaws.com\/ent.news\/audio\/2025\/1\/.3d726198-3f97-41d0-90c6-cc1b54df459d.mp3"},"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v27.1 (Yoast SEO v27.1.1) - https:\/\/yoast.com\/product\/yoast-seo-premium-wordpress\/ -->\n<title>Mubadala\u2019s KELIX bio acquires DiabTec - UAE<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/enterpriseam.com\/uae\/2025\/01\/17\/mubadalas-kelix-bio-acquires-diabtec\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Mubadala\u2019s KELIX bio acquires DiabTec\" \/>\n<meta property=\"og:description\" content=\"The acquisition includes DiabTec\u2019s state-of-the-art facility, built to EU and US FDA standards\" \/>\n<meta property=\"og:url\" content=\"https:\/\/enterpriseam.com\/uae\/2025\/01\/17\/mubadalas-kelix-bio-acquires-diabtec\/\" \/>\n<meta property=\"og:site_name\" content=\"UAE\" \/>\n<meta property=\"article:published_time\" content=\"2025-01-17T00:00:00+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/i0.wp.com\/ent.news\/2024\/2\/1557.jpg?fit=%2C&ssl=1\" \/>\n<meta name=\"author\" content=\"enterpriseam admin\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"enterpriseam admin\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/enterpriseam.com\/uae\/2025\/01\/17\/mubadalas-kelix-bio-acquires-diabtec\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/enterpriseam.com\/uae\/2025\/01\/17\/mubadalas-kelix-bio-acquires-diabtec\/\"},\"author\":{\"name\":\"enterpriseam admin\",\"@id\":\"https:\/\/enterpriseam.com\/uae\/#\/schema\/person\/ca597032db7e4db868359c123cec256d\"},\"headline\":\"Mubadala\u2019s KELIX bio acquires DiabTec\",\"datePublished\":\"2025-01-17T00:00:00+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/enterpriseam.com\/uae\/2025\/01\/17\/mubadalas-kelix-bio-acquires-diabtec\/\"},\"wordCount\":324,\"publisher\":{\"@id\":\"https:\/\/enterpriseam.com\/uae\/#organization\"},\"image\":{\"@id\":\"https:\/\/enterpriseam.com\/uae\/2025\/01\/17\/mubadalas-kelix-bio-acquires-diabtec\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/i0.wp.com\/ent.news\/2024\/2\/1557.jpg?fit=%2C&ssl=1\",\"keywords\":[\"EnterpriseAM UAE\",\"Healthcare\",\"Julphar\",\"M&amp;A WATCH\",\"Mubadala\",\"pharmaceuticals\"],\"articleSection\":[\"M&amp;A WATCH\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/enterpriseam.com\/uae\/2025\/01\/17\/mubadalas-kelix-bio-acquires-diabtec\/\",\"url\":\"https:\/\/enterpriseam.com\/uae\/2025\/01\/17\/mubadalas-kelix-bio-acquires-diabtec\/\",\"name\":\"Mubadala\u2019s KELIX bio acquires DiabTec - UAE\",\"isPartOf\":{\"@id\":\"https:\/\/enterpriseam.com\/uae\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/enterpriseam.com\/uae\/2025\/01\/17\/mubadalas-kelix-bio-acquires-diabtec\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/enterpriseam.com\/uae\/2025\/01\/17\/mubadalas-kelix-bio-acquires-diabtec\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/i0.wp.com\/ent.news\/2024\/2\/1557.jpg?fit=%2C&ssl=1\",\"datePublished\":\"2025-01-17T00:00:00+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/enterpriseam.com\/uae\/2025\/01\/17\/mubadalas-kelix-bio-acquires-diabtec\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/enterpriseam.com\/uae\/2025\/01\/17\/mubadalas-kelix-bio-acquires-diabtec\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/enterpriseam.com\/uae\/2025\/01\/17\/mubadalas-kelix-bio-acquires-diabtec\/#primaryimage\",\"url\":\"https:\/\/i0.wp.com\/ent.news\/2024\/2\/1557.jpg?fit=%2C&ssl=1\",\"contentUrl\":\"https:\/\/i0.wp.com\/ent.news\/2024\/2\/1557.jpg?fit=%2C&ssl=1\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/enterpriseam.com\/uae\/2025\/01\/17\/mubadalas-kelix-bio-acquires-diabtec\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/enterpriseam.com\/uae\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Mubadala\u2019s KELIX bio acquires DiabTec\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/enterpriseam.com\/uae\/#website\",\"url\":\"https:\/\/enterpriseam.com\/uae\/\",\"name\":\"UAE\",\"description\":\"The State of the Nation\",\"publisher\":{\"@id\":\"https:\/\/enterpriseam.com\/uae\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/enterpriseam.com\/uae\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/enterpriseam.com\/uae\/#organization\",\"name\":\"UAE\",\"url\":\"https:\/\/enterpriseam.com\/uae\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/enterpriseam.com\/uae\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/ent.news\/internal\/42998.svg\",\"contentUrl\":\"https:\/\/ent.news\/internal\/42998.svg\",\"caption\":\"UAE\"},\"image\":{\"@id\":\"https:\/\/enterpriseam.com\/uae\/#\/schema\/logo\/image\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\/\/enterpriseam.com\/uae\/#\/schema\/person\/ca597032db7e4db868359c123cec256d\",\"name\":\"enterpriseam admin\",\"sameAs\":[\"http:\/\/enterpriseam.testing.projectsarea.com\"],\"url\":\"https:\/\/enterpriseam.com\/uae\/author\/enterpriseam\/\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Mubadala\u2019s KELIX bio acquires DiabTec - UAE","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/enterpriseam.com\/uae\/2025\/01\/17\/mubadalas-kelix-bio-acquires-diabtec\/","og_locale":"en_US","og_type":"article","og_title":"Mubadala\u2019s KELIX bio acquires DiabTec","og_description":"The acquisition includes DiabTec\u2019s state-of-the-art facility, built to EU and US FDA standards","og_url":"https:\/\/enterpriseam.com\/uae\/2025\/01\/17\/mubadalas-kelix-bio-acquires-diabtec\/","og_site_name":"UAE","article_published_time":"2025-01-17T00:00:00+00:00","og_image":[{"url":"https:\/\/i0.wp.com\/ent.news\/2024\/2\/1557.jpg?fit=%2C&ssl=1","type":"","width":"","height":""}],"author":"enterpriseam admin","twitter_card":"summary_large_image","twitter_misc":{"Written by":"enterpriseam admin","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/enterpriseam.com\/uae\/2025\/01\/17\/mubadalas-kelix-bio-acquires-diabtec\/#article","isPartOf":{"@id":"https:\/\/enterpriseam.com\/uae\/2025\/01\/17\/mubadalas-kelix-bio-acquires-diabtec\/"},"author":{"name":"enterpriseam admin","@id":"https:\/\/enterpriseam.com\/uae\/#\/schema\/person\/ca597032db7e4db868359c123cec256d"},"headline":"Mubadala\u2019s KELIX bio acquires DiabTec","datePublished":"2025-01-17T00:00:00+00:00","mainEntityOfPage":{"@id":"https:\/\/enterpriseam.com\/uae\/2025\/01\/17\/mubadalas-kelix-bio-acquires-diabtec\/"},"wordCount":324,"publisher":{"@id":"https:\/\/enterpriseam.com\/uae\/#organization"},"image":{"@id":"https:\/\/enterpriseam.com\/uae\/2025\/01\/17\/mubadalas-kelix-bio-acquires-diabtec\/#primaryimage"},"thumbnailUrl":"https:\/\/i0.wp.com\/ent.news\/2024\/2\/1557.jpg?fit=%2C&ssl=1","keywords":["EnterpriseAM UAE","Healthcare","Julphar","M&amp;A WATCH","Mubadala","pharmaceuticals"],"articleSection":["M&amp;A WATCH"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/enterpriseam.com\/uae\/2025\/01\/17\/mubadalas-kelix-bio-acquires-diabtec\/","url":"https:\/\/enterpriseam.com\/uae\/2025\/01\/17\/mubadalas-kelix-bio-acquires-diabtec\/","name":"Mubadala\u2019s KELIX bio acquires DiabTec - UAE","isPartOf":{"@id":"https:\/\/enterpriseam.com\/uae\/#website"},"primaryImageOfPage":{"@id":"https:\/\/enterpriseam.com\/uae\/2025\/01\/17\/mubadalas-kelix-bio-acquires-diabtec\/#primaryimage"},"image":{"@id":"https:\/\/enterpriseam.com\/uae\/2025\/01\/17\/mubadalas-kelix-bio-acquires-diabtec\/#primaryimage"},"thumbnailUrl":"https:\/\/i0.wp.com\/ent.news\/2024\/2\/1557.jpg?fit=%2C&ssl=1","datePublished":"2025-01-17T00:00:00+00:00","breadcrumb":{"@id":"https:\/\/enterpriseam.com\/uae\/2025\/01\/17\/mubadalas-kelix-bio-acquires-diabtec\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/enterpriseam.com\/uae\/2025\/01\/17\/mubadalas-kelix-bio-acquires-diabtec\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/enterpriseam.com\/uae\/2025\/01\/17\/mubadalas-kelix-bio-acquires-diabtec\/#primaryimage","url":"https:\/\/i0.wp.com\/ent.news\/2024\/2\/1557.jpg?fit=%2C&ssl=1","contentUrl":"https:\/\/i0.wp.com\/ent.news\/2024\/2\/1557.jpg?fit=%2C&ssl=1"},{"@type":"BreadcrumbList","@id":"https:\/\/enterpriseam.com\/uae\/2025\/01\/17\/mubadalas-kelix-bio-acquires-diabtec\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/enterpriseam.com\/uae\/"},{"@type":"ListItem","position":2,"name":"Mubadala\u2019s KELIX bio acquires DiabTec"}]},{"@type":"WebSite","@id":"https:\/\/enterpriseam.com\/uae\/#website","url":"https:\/\/enterpriseam.com\/uae\/","name":"UAE","description":"The State of the Nation","publisher":{"@id":"https:\/\/enterpriseam.com\/uae\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/enterpriseam.com\/uae\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/enterpriseam.com\/uae\/#organization","name":"UAE","url":"https:\/\/enterpriseam.com\/uae\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/enterpriseam.com\/uae\/#\/schema\/logo\/image\/","url":"https:\/\/ent.news\/internal\/42998.svg","contentUrl":"https:\/\/ent.news\/internal\/42998.svg","caption":"UAE"},"image":{"@id":"https:\/\/enterpriseam.com\/uae\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/enterpriseam.com\/uae\/#\/schema\/person\/ca597032db7e4db868359c123cec256d","name":"enterpriseam admin","sameAs":["http:\/\/enterpriseam.testing.projectsarea.com"],"url":"https:\/\/enterpriseam.com\/uae\/author\/enterpriseam\/"}]}},"featured_image_src":"https:\/\/i0.wp.com\/ent.news\/2024\/2\/1557.jpg?resize=600%2C400&ssl=1","featured_image_src_square":"https:\/\/i0.wp.com\/ent.news\/2024\/2\/1557.jpg?resize=600%2C600&ssl=1","author_info":{"display_name":"enterpriseam admin","author_link":"https:\/\/enterpriseam.com\/uae\/author\/enterpriseam\/"},"jetpack_featured_media_url":"https:\/\/i0.wp.com\/ent.news\/2024\/2\/1557.jpg?fit=%2C&ssl=1","jetpack_sharing_enabled":true,"jetpack-related-posts":[],"_links":{"self":[{"href":"https:\/\/enterpriseam.com\/uae\/wp-json\/wp\/v2\/posts\/99765","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/enterpriseam.com\/uae\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/enterpriseam.com\/uae\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/enterpriseam.com\/uae\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/enterpriseam.com\/uae\/wp-json\/wp\/v2\/comments?post=99765"}],"version-history":[{"count":0,"href":"https:\/\/enterpriseam.com\/uae\/wp-json\/wp\/v2\/posts\/99765\/revisions"}],"acf:post":[{"embeddable":true,"href":"https:\/\/enterpriseam.com\/uae\/wp-json\/wp\/v2\/issue\/99760"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/enterpriseam.com\/uae\/wp-json\/wp\/v2\/media\/99766"}],"wp:attachment":[{"href":"https:\/\/enterpriseam.com\/uae\/wp-json\/wp\/v2\/media?parent=99765"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/enterpriseam.com\/uae\/wp-json\/wp\/v2\/categories?post=99765"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/enterpriseam.com\/uae\/wp-json\/wp\/v2\/tags?post=99765"},{"taxonomy":"brand","embeddable":true,"href":"https:\/\/enterpriseam.com\/uae\/wp-json\/wp\/v2\/brand?post=99765"},{"taxonomy":"newspack_spnsrs_tax","embeddable":true,"href":"https:\/\/enterpriseam.com\/uae\/wp-json\/wp\/v2\/newspack_spnsrs_tax?post=99765"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}